Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2025
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals held its 35th Annual General Meeting on September 29, 2025, from 11:00 AM to 11:20 AM via video conferencing, chaired by Mr. Mihir Ghatalia. Seven ordinary business resolutions were put to shareholders, including adoption of audited financial statements for FY 2024-25, re-appointment of Mr. Mihir Ghatalia as director (retiring by rotation), and re-appointment of M/s. Motilal & Associates as statutory auditors for a second five-year term. Other resolutions covered the re-appointment of Mr. Chetan K Mehta as Independent Director for a second five-year term, appointment of M/s. Ashika Shetty as Secretarial Auditors, continuation of Mr. Nimit Ghatalia as Executive Director, and approval of related party transactions. The company provided both remote e-voting and venue e-voting facilities, with Mr. Virendra Bhatt acting as scrutinizer. Detailed voting results are to be submitted to the stock exchanges within two working days.
This is a routine procedural disclosure confirming the AGM was conducted as planned and standard governance items were put to vote. No major strategic announcements or surprises were made; shareholders should wait for the formal voting results to confirm approval of each resolution, particularly the related party transactions.